Sponsors  

Aspect Medical Systems - http://www.aspectmedical.com/products/technology/vista.mspx
BIS™ Vista Proven BIS™ technology in a fully-featured stand-alone monitor, Full-color, touch screen navigation, Larger LCD display, Enhanced processing power and increased case storage, USB ports for system expandability and real time updates, Utilizes the BISx platform.
NeurOptics Pupillometer - http://www.neuroptics.com/?p=3
The NeurOptics Pupillometer is a hand-held, cordless, and simple to use device which takes away all subjectivity in the measurement of the pupillary light reflex (PLR). Now even the smallest changes in pupillary function which are not discernable to the naked eye are detectable by clinicians and can be measured and quantified.
Medivance - http://www.medivance.com/html/Products/feat_benefits.html
The Arctic Sun Temperature Management System offers a unique, sophisticated approach to patient cooling. This novel technology, with its ease of use and precision, has been used to control neurogenic fever and provide therapeutic hypothermia in thousands of critically ill patients worldwide.
Brain Trauma Foundation (BTF) - http://www.braintrauma.org
Founded in 1986 as a non-profit organization to improve outcomes for Traumatic Brain Injury (TBI) patients. TBI, usually from car crashes but also falls and sport injuries, is the leading cause of death and disability in children and young adults. BTF is the only organization of its kind dedicated to improving TBI care during the acute phase after injury, in the ambulance and in the hospital. By educating medical professionals in this area, thousands of lives can be saved each year in the U.S. and thousands more will be spared life long permanent disabilities.
Intergra Licox® - http://www.integra-ls.com/products/?product=48
In the last decade, clinical researchers have demonstrated the significance of oxygen partial pressure measurements in the brain. A study by van Santbrink, et al (2000), examined brain tissue oxygenation (pBtO2) in 101 head trauma patients (Glasgow Coma Scale <8) using LICOX®. Despite aggressive conventional monitoring and treatment, hypoxic events were observed with the LICOX® system in more than half of these patients. The depth and duration of tissue hypoxia were related to outcome, and proved to be an independent predictor of unfavorable outcome and death.